Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Publisher Correction: PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.

Benitez JA, Ma J, D'Antonio M, Boyer A, Camargo MF, Zanca C, Kelly S, Khodadadi-Jamayran A, Jameson NM, Andersen M, Miletic H, Saberi S, Frazer KA, Cavenee WK, Furnari FB.

Nat Commun. 2018 May 25;9:16217. doi: 10.1038/ncomms16217.

2.

Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.

Cosset É, Ilmjärv S, Dutoit V, Elliott K, von Schalscha T, Camargo MF, Reiss A, Moroishi T, Seguin L, Gomez G, Moo JS, Preynat-Seauve O, Krause KH, Chneiweiss H, Sarkaria JN, Guan KL, Dietrich PY, Weis SM, Mischel PS, Cheresh DA.

Cancer Cell. 2017 Dec 11;32(6):856-868.e5. doi: 10.1016/j.ccell.2017.10.016. Epub 2017 Nov 30.

PMID:
29198914
3.

Prospective cohort analyzing risk factors for chronic kidney disease progression in children.

Belangero VMS, Prates LC, Watanabe A, Schvartsman BSG, Nussenzveig P, Cruz NA, Abreu ALS, Paz IP, Facincani I, Morgantetti FEC, Silva AO, Andrade OVB, Camargo MFC, Nogueira PCK.

J Pediatr (Rio J). 2018 Sep - Oct;94(5):525-531. doi: 10.1016/j.jped.2017.07.015. Epub 2017 Oct 2.

4.

Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers.

Seguin L, Camargo MF, Wettersten HI, Kato S, Desgrosellier JS, von Schalscha T, Elliott KC, Cosset E, Lesperance J, Weis SM, Cheresh DA.

Cancer Discov. 2017 Dec;7(12):1464-1479. doi: 10.1158/2159-8290.CD-17-0539. Epub 2017 Sep 11.

PMID:
28893801
5.

Cost analysis of substitutive renal therapies in children.

Camargo MFC, Barbosa KS, Fetter SK, Bastos A, Feltran LS, Koch-Nogueira PC.

J Pediatr (Rio J). 2018 Jan - Feb;94(1):93-99. doi: 10.1016/j.jped.2017.05.004. Epub 2017 Jul 24.

6.

Targeted Next-Generation Sequencing in Brazilian Children With Nephrotic Syndrome Submitted to Renal Transplant.

Feltran LS, Varela P, Silva ED, Veronez CL, Franco MC, Filho AP, Camargo MF, Koch Nogueira PC, Pesquero JB.

Transplantation. 2017 Dec;101(12):2905-2912. doi: 10.1097/TP.0000000000001846.

PMID:
28658201
7.

PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.

Benitez JA, Ma J, D'Antonio M, Boyer A, Camargo MF, Zanca C, Kelly S, Khodadadi-Jamayran A, Jameson NM, Andersen M, Miletic H, Saberi S, Frazer KA, Cavenee WK, Furnari FB.

Nat Commun. 2017 May 12;8:15223. doi: 10.1038/ncomms15223. Erratum in: Nat Commun. 2018 May 25;9:16217.

8.

Kinase-independent role for CRAF-driving tumour radioresistance via CHK2.

Advani SJ, Camargo MF, Seguin L, Mielgo A, Anand S, Hicks AM, Aguilera J, Franovic A, Weis SM, Cheresh DA.

Nat Commun. 2015 Sep 3;6:8154. doi: 10.1038/ncomms9154.

9.

Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescence.

Franovic A, Elliott KC, Seguin L, Camargo MF, Weis SM, Cheresh DA.

Cancer Res. 2015 Nov 1;75(21):4466-73. doi: 10.1158/0008-5472.CAN-15-0988. Epub 2015 Aug 21.

10.

Pediatric Chronic Dialysis in Brazil: Epidemiology and Regional Inequalities.

Konstantyner T, Sesso R, de Camargo MF, de Santis Feltran L, Koch-Nogueira PC.

PLoS One. 2015 Aug 18;10(8):e0135649. doi: 10.1371/journal.pone.0135649. eCollection 2015.

11.

An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.

Seguin L, Kato S, Franovic A, Camargo MF, Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, Cascone T, Diao L, Wang J, Wistuba II, Heymach JV, Lippman SM, Desgrosellier JS, Anand S, Weis SM, Cheresh DA.

Nat Cell Biol. 2014 May;16(5):457-68. doi: 10.1038/ncb2953. Epub 2014 Apr 20.

12.

Vascular anastomosis for paediatric renal transplantation and new strategy in low-weight children.

Gomes AL, Koch-Nogueira PC, de Camargo MF, Feltran Lde S, Baptista-Silva JC.

Pediatr Transplant. 2014 Jun;18(4):342-9. doi: 10.1111/petr.12248. Epub 2014 Mar 20.

PMID:
24646422
13.

Growth of children with end-stage renal disease undergoing daily hemodialysis.

de Camargo MF, Henriques CL, Vieira S, Komi S, Leão ER, Nogueira PC.

Pediatr Nephrol. 2014 Mar;29(3):439-44. doi: 10.1007/s00467-013-2676-4. Epub 2013 Nov 20.

PMID:
24253592
14.

A MEK-independent role for CRAF in mitosis and tumor progression.

Mielgo A, Seguin L, Huang M, Camargo MF, Anand S, Franovic A, Weis SM, Advani SJ, Murphy EA, Cheresh DA.

Nat Med. 2011 Nov 13;17(12):1641-5. doi: 10.1038/nm.2464.

15.

Estimated prevalence of childhood end-stage renal disease in the state of São Paulo.

Nogueira PC, Feltran Lde S, Camargo MF, Leão ER, Benninghoven JR, Gonçalves NZ, Pereira LA, Sesso RC.

Rev Assoc Med Bras (1992). 2011 Jul-Aug;57(4):436-41.

16.

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.

Candelaria M, Gallardo-Rincón D, Arce C, Cetina L, Aguilar-Ponce JL, Arrieta O, González-Fierro A, Chávez-Blanco A, de la Cruz-Hernández E, Camargo MF, Trejo-Becerril C, Pérez-Cárdenas E, Pérez-Plasencia C, Taja-Chayeb L, Wegman-Ostrosky T, Revilla-Vazquez A, Dueñas-González A.

Ann Oncol. 2007 Sep;18(9):1529-38.

PMID:
17761710
17.

[Analysis of the intracuff pressures of intensive care patients].

Camargo MF, Andrade AP, Cardoso FP, Melo Mdo H.

Rev Assoc Med Bras (1992). 2006 Nov-Dec;52(6):405-8. Portuguese.

18.

A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.

Arce C, Pérez-Plasencia C, González-Fierro A, de la Cruz-Hernández E, Revilla-Vázquez A, Chávez-Blanco A, Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, Bargallo E, Villarreal P, Ramírez T, Vela T, Candelaria M, Camargo MF, Robles E, Dueñas-González A.

PLoS One. 2006 Dec 20;1:e98.

19.

Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease.

Etchebehere EC, Cendes F, Lopes-Cendes I, Pereira JA, Lima MC, Sansana CR, Silva CA, Camargo MF, Santos AO, Ramos CD, Camargo EE.

Arch Neurol. 2001 Aug;58(8):1257-63.

PMID:
11493166

Supplemental Content

Loading ...
Support Center